ClinicalTrials.Veeva

Menu

VitalScan MCG Rule-out Multi-centre Pivotal Study - US (MAGNET ACS)

C

Creavo Medical Technologies

Status

Terminated

Conditions

Acute Coronary Syndrome

Treatments

Device: VitalScan Magnetocardiograph

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT03546933
CIP 003 (US)

Details and patient eligibility

About

A prospective multi-centre observational study to validate the diagnostic accuracy of a transportable magnetocardiograph device for acute coronary syndrome (ACS), focusing on rule-out capability, in patients who present to the emergency department with chest pain symptoms consistent with ACS.

Enrollment

651 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient presents to the ED with chest pain syndrome of suspected cardiac origin (i.e. symptoms consistent with ACS)
  • 18+ year old male or female
  • Patient is willing and able to give written informed consent

Exclusion criteria

  • ST-segment Elevation MI (STEMI)
  • Clear non-ischemic cause for symptoms (e.g. trauma)
  • Hemodynamic instability on admission (e.g. BP>220mmHg systolic & >110mmHg diastolic, <80mmHg systolic & <40mmHg diastolic, HR>160bpm)
  • Ventricular tachycardia or fibrillation that cannot be treated effectively
  • Atrial fibrillation
  • Thoracic metal implants
  • Pacemaker or internal defibrillator
  • Pregnancy (if after 20-week period)* or lactation
  • Patient unable to lie down (i.e. supine position) or stay still on the examination bed
  • Patient unable to understand the informed consent process and/or has a poor understanding of English (e.g. English- speaking relative/translator not available)
  • Patient unable to comply with the requirements of the protocol

Trial design

651 participants in 1 patient group

Chest pain patients presenting to the ED
Description:
All patients that present to the emergency department with chest pain and potentially other symptoms consistent with ACS and meet all eligibility criteria will undergo VitalScan Magnetocardiograph.
Treatment:
Device: VitalScan Magnetocardiograph

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems